Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix

W J Lane1, S Dias, K Hattori

  • 1Division of Hematology-Oncology, Weill Medical College of Cornell University, Ithaca, NY 10021, USA.

Blood
|December 9, 2000
PubMed

Insights

Mature megakaryocytes (MKs) migrate and release platelets by expressing matrix metalloproteinase-9 (MMP-9), a process stimulated by stromal-derived factor 1 (SDF-1) and its receptor CXCR4. MMP inhibitors may treat blood disorders.

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Thrombopoietin (TPO) is known to influence megakaryocytopoiesis, but the precise mechanisms and locations of platelet production remain unclear.
  • Mature megakaryocytes (MKs) express the stromal-derived factor 1 (SDF-1) receptor, CXCR4, and SDF-1 induces their migration through endothelial cells, enhancing platelet production.

Purpose of the Study:

  • To investigate the role of matrix metalloproteinases (MMPs) in megakaryocyte migration and platelet production.
  • To determine if SDF-1 induces MMP expression in MKs and if MMPs are essential for MK migration and platelet release.

Main Methods:

  • Purified mature human MKs and a megakaryocytic cell line were used to assess SDF-1-induced expression and release of MMP-9.
  • Neutralizing antibodies against MMP-9 and MMP-2 were employed to evaluate their role in MK migration.
  • Synthetic MMP inhibitors were used to assess their impact on platelet formation.
  • Adeno-SDF-1 was injected into mice to confirm findings in vivo, with subsequent analysis of platelet counts and MMP inhibitor effects.

Main Results:

  • SDF-1 stimulated the expression and release of gelatinase B (MMP-9) by mature MKs and a megakaryocytic cell line.
  • Neutralization of MMP-9, but not MMP-2, inhibited SDF-1-induced MK migration through basement membrane.
  • MMP inhibitors blocked both MK migration and subsequent platelet formation.
  • In vivo administration of adeno-SDF-1 increased platelet counts in mice, an effect reversible by MMP inhibitors.

Conclusions:

  • Megakaryocyte (MK) mobilization involves sequential expression and activation of CXCR4 and MMP-9, leading to transendothelial migration and platelet release.
  • Matrix metalloproteinase-9 (MMP-9) plays a critical role in both MK migration and platelet formation.
  • Matrix metalloproteinase (MMP) inhibitors show potential therapeutic value for thrombotic and myeloproliferative disorders.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...